menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Controversies in Drug Pricing: How Will Capitol Hill Respond?

Interest in health policies related to drug pricing has spiked in recent times. While remarkable research discoveries have positively escalated the...
  • Overview

    Interest in health policies related to drug pricing has spiked in recent times. While remarkable research discoveries have positively escalated the pharmaceutical industry with release of more novel drugs, the question on how drugs should be priced is continually resurfacing. How are high drug costs justified when they become financially inaccessible to many patients, and what measures are being put in place to address these access gaps?

    Host Frank Russomano welcomes Andrew Rosenberg J.D. of the CME Coalition and Thomas Sullivan, President of Rockpointe Corporation and editor of Policy and Medicine, to discuss recent developments in drug pricing.

     

    Host Frank Russomano welcomes Andrew Rosenberg J.D. of the CME Coalition and Thomas Sullivan, President of Rockpointe Corporation and editor of Policy and Medicine. - See more at: https://reachmd.com/programs/voices-from-american-medicine/all-things-educational-panel-discusses-independent-cme-sunshine-act-reporting/7901/#sthash.CkKA6uPe.dpuf

     

Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.